NIDA

NIDA Releases Its 2022-2026 Strategic Plan

News

This week, NIDA releases its strategic plan for FY 2022-2026. Strategic planning is a process all NIH Institutes perform every five years, to take stock of the current state of research and set priorities that are ambitious but achievable...

2022 NIDA International Forum

9 June 2022

Online

The NIDA International Forum fosters international cooperative research and the exchange of scientific information by substance use researchers and highlights the range and quality of substance use and

Longitudinal Impact of Childhood Adversity on Early Adolescent Mental Health During the COVID-19 Pandemic in the ABCD Study Cohort: Does Race or Ethnicity Moderate Findings?

Scientific article

Abstract Background During the COVID-19 pandemic in the United States, mental health among youth has been negatively affected. Youth with a history of adverse childhood experiences (ACEs), as well as youth from minoritized racial-ethnic...

NIH Workshop on Psychedelics as Therapeutics: Gaps, Challenges and Opportunities

12 January 2022

Washington DC

United States

Register now: https://www.eventbrite.com/e/workshop-on-psychedelics-as-therapeutics-gaps-challenges-opportunities-tickets-216497739567?keep_tld=1

The NIH Workshop on Psychedelics as Therapeutics is sponsored by the National Institute of Mental Health,

Un Enfoque Neurocientífico de la Adicción y su Prevención

6 December 2021

Ciudad de México

Mexico

Registro gratuito en: https://zoom.us/webinar/register/4716363937936/WN_PItjnKBVSnioKSA9py5adw

Lunes 6 de diciembre del 2021, a partir de las 17:00 (hora de la Ciudad de México)

The NIDA Clinical Trials Network: Evolving, Expanding, and Addressing the Opioid Epidemic

Scientific article

8 May 2021

Abstract Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a nationwide consortium...

Younger age of first cannabis use or prescription drug misuse is associated with faster development of substance use disorders

News

NIH analysis measures the prevalence of nine substance use disorders after first substance use or misuse in young people.

COVID-19: Potential Implications for Individuals with Substance Use Disorders

Book

6 April 2020

As people across the U.S. and the rest of the world contend with coronavirus disease 2019 (COVID-19), this article warns that the research community should be alert to the possibility that it could hit some populations with substance use...

25th NIDA International Forum

19 June 2020

Hollywood, Florida

United States

The National Institute on

NIDA's International Program Director and Humphrey Fellows Gather in Nairobi

News

NIDA's International Program Director Steven W. Gust, Ph.D., moderated a session on research and training during a session at the Fourth Annual Meeting of the International Society of Substance Use Professionals (ISSUP). The African Union...